Morgan Stanley downgrades CME Group ($CME) to Overweight, sets $324 target: here’s how the stock has moved on similar analyst actions
How CME has reacted before
| Report | Next-day move |
|---|---|
| Jul 10, 2026 | +0.2% |
| Jul 09, 2026 | -1.4% |
| Jul 06, 2026 | -0.8% |
| Jun 18, 2026 | -2.4% |
| Jun 11, 2026 | -0.6% |
| Jan 15, 2026 | -1.0% |
| Jan 14, 2026 | +2.5% |
| Dec 22, 2025 | +1.5% |
| Dec 12, 2025 | +0.4% |
Median absolute move 1% · higher 4 of 9 · n=9
The call
- Firm: Morgan Stanley
- Action: Downgrades
- Rating: Overweight
- Price target: $324.00
How $CME moves around analyst actions
| Date | Session move |
|---|---|
| Jul 10, 2026 | +0.2% |
| Jul 09, 2026 | -1.4% |
| Jul 06, 2026 | -0.8% |
| Jun 18, 2026 | -2.4% |
| Jun 11, 2026 | -0.6% |
| Jan 15, 2026 | -1.0% |
| Jan 14, 2026 | +2.5% |
| Dec 22, 2025 | +1.5% |
| Dec 12, 2025 | +0.4% |
Base rate (n=9):
- Median absolute move: 1.0%
- Higher: 4 of 9
- Biggest up: +2.5%
- Biggest down: -2.4%